A detailed history of Glaxis Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Glaxis Capital Management, LLC holds 2,500 shares of AMGN stock, worth $777,200. This represents 1.36% of its overall portfolio holdings.

Number of Shares
2,500
Holding current value
$777,200
% of portfolio
1.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $672,175 - $811,400
2,500 New
2,500 $710,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Glaxis Capital Management, LLC Portfolio

Follow Glaxis Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glaxis Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glaxis Capital Management, LLC with notifications on news.